ArticleJACC. Basic to translational science2026
Feasibility of Magnetic Resonance Imaging-Guided Pulmonary Artery Stenting in a Commercial Wide-Bore 0.55-T Scanner.
Article in JACC. Basic to translational science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
Real-time pulmonary artery (PA) stenting under magnetic resonance imaging (MRI) guidance may eliminate radiation exposure during complex vascular interventions. This study evaluated the feasibility of performing PA stenting in a swine model using a commercially available 0.55-T MRI system with ferumoxytol-enhanced imaging. Ten juvenile pigs underwent attempts at MRI-guided PA stent deployment using stainless-steel balloon-expandable stents. Stenting was successful in 7 animals, with all successes achieved after switching from femoral to external jugular venous access. Real-time gradient echo imaging provided sufficient visualization for catheter navigation, device delivery, and stent deployment. Postdeployment phase contrast imaging demonstrated flow continuity, minimal artifact, and trivial pressure gradients across the stent (0.2 ± 0.12 mm Hg). Peak velocities increased by 21.2 ± 7.0 cm/s distal to the stent, confirming preserved patency. These findings demonstrate the technical feasibility of CMR-guided PA stenting at 0.55-T and support the potential for future radiation-free PA interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.